(Q34303679)

1 August 2017

1 reference

title

Insulin-like growth factor I and prostate cancer (English)

1 reference

1 August 2017

1 reference

O'Brien MF

1

1 reference

1 August 2017

Watson RW

series ordinal

2

1 reference

1 August 2017

Fitzpatrick JM

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

58

1 reference

1 August 2017

1-7

1 reference

1 August 2017

1

1 reference

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

The insulin-like growth factor-binding protein (IGFBP) superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Regulation of DU145 human prostate cancer cell proliferation by insulin-like growth factors and its interaction with the epidermal growth factor autocrine loop

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Apoptosis, tumour invasion and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Growth regulation of prostatic stromal cells by prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Serum insulin-like growth factor-1 is not a useful marker of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Serum insulin-like growth factor-I levels and prostate cancer risk--interpreting the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901004-4

7 January 2021

10.1016/S0090-4295(01)01004-4

Identifiers

DOI

1 reference

release_6meuoitsyng7rneyl4dacu6hri

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6meuoitsyng7rneyl4dacu6hri

24 November 2022

mapped directly with Wikidata item

1 reference